Table 2.
National prevalence of anti-HCV antibodies by sociodemographic characteristics in Mexican population aged 50 years and more. ENSANUT 2018.
| Prevalence (95% CI) | P-value | Estimated cases (n/N) | |
|---|---|---|---|
| Age group (years) | 0·03 | ||
| 50-59 | 0·16 (0·07, 0·38) | 7/22000 | |
| 60-69 | 0·81 (0·41, 1·59) | 14/83000 | |
| 70 or more | 1·07 (0·38, 2·98) | 14/90000 | |
| Marital status | 0·20 | ||
| Single | 0·75 (0·23, 2·37) | 4/23000 | |
| Cohabitating | 0·43 (0·24, 0·76) | 22/88000 | |
| Separated | 0·37 (0·11, 1·31) | 4/12000 | |
| Widowed | 1·29 (0·35, 4·64) | 5/72000 | |
| Education | 0·90 | ||
| Elementary or less | 0·65 (0·30, 1·41) | 25/124000 | |
| Middle/High school | 0·52 (0·20, 1·33) | 7/52000 | |
| College and higher | 0·57 (0·17, 1·84) | 3/19000 | |
| Country region | 0·7 | ||
| Centre | 0·32 (0·10, 0·98) | 5/23000 | |
| North | 0·55 (0·25, 1·22) | 12/53000 | |
| Mexico Citya | 0·73 (0·10, 4·96) | 1/44000 | |
| South | 0·79 (0·42, 1·49) | 17/74000 | |
| Sex | 0·75 | ||
| Men | 0·55 (0·31, 0·96) | 20/77000 | |
| Women | 0·64 (0·27, 1·51) | 15/118000 | |
| Area | 0·69 | ||
| Rural | 0·71 (0·30, 1·65) | 11/45000 | |
| Urban | 0·57 (0·29, 1·14) | 24/150000 | |
| Socioeconomic status | 0·78 | ||
| Low | 0·54 (0·28, 1·06) | 15/52000 | |
| Medium | 0·50 (0·22, 1·14) | 9/51000 | |
| High | 0·72 (0·25, 2·03) | 11/92000 | |
| Prior HCV diagnosis | 0·84 | ||
| No | 0·62 (0·35, 1·08) | 35/195000 | |
| Yes | 0·00 (0·00, 0·00) | 0/0 | |
| Does not know/remember | 0·00 (0·00, 0·00) | 0/0 | |
| Did not answer | 0·00 (0·00, 0·00) | 0/0 | |
| Blood transfusion before 1995 | 0·67 | ||
| No | 0·66 (0·36, 1·21) | 29/171000 | |
| Yes | 0·00 (0·00, 0·00) | 0/0 | |
| Does not know/remember | 0·72 (0·12, 4·08) | 3/20 | |
| Did not answer | 0·13 (0·04, 0·44) | 3/3000 |
Sample size: 4935 which represents 32 million 466 thousand inhabitants. aIncludes surrounding urban municipalities. N is weighted sample and n is the study sample. N may not add up to 195 000 due to rounding.